Elias Tsepouridis

Elias Tsepouridis has an extensive work experience in finance leadership roles. Elias currently holds the position of Vice President of Finance, FP&A and Business Development at BeiGene. Prior to their current role, they served as the B&SH and Surgical Divisional CFO at Hologic, Inc. where they were responsible for overseeing the finance and accounting function for two business units with a revenue scope of $1.6 billion. Elias also worked as a Senior Finance Director and Finance Controller at J&J - Janssen Research and Development, where they managed large R&D expenses and provided financial oversight for the Oncology and Diagnostics R&D portfolio. Before that, they were the Finance Director at Johnson & Johnson Medical Device Sector, overseeing financial activities for distribution activities and leading a team of 13 employees. Elias also gained experience in finance roles at DePuy Orthopaedics and Johnson & Johnson, where they served as a WW Ops Finance Manager and M&A Finance Manager respectively. Additionally, they worked at Johnson & Johnson, McNeil Nutritionals as a Worldwide Financial Reporting Manager and Senior Financial Analyst. Elias started their career at Johnson & Johnson as part of their FLDP program.

Elias Tsepouridis received their MBA in Finance & Economics from the Questrom School of Business, Boston University, from 2008 to 2012. Prior to that, they obtained their undergraduate degree in Finance from Drexel University's LeBow College of Business, from 1994 to 1999. There is no information available regarding their education prior to attending Drexel University.